What is Medminder Systems?
MedMinder pill dispensers are designed to enhance medication adherence through a system of customizable visual and auditory alerts. Founded in 2007 and based in Newton, Massachusetts, MedMinder Systems addresses a critical need in patient care by providing a reliable tool to help users manage their medication schedules effectively. The company's technology aims to reduce missed doses and improve health outcomes for individuals managing chronic conditions or complex treatment regimens.
How much funding has Medminder Systems raised?
Medminder Systems has raised a total of $89.6M across 8 funding rounds:
Unspecified
$500K
Private Equity
$1.3M
Private Equity
$850K
Private Equity
$1.4M
Private Equity
$610K
Unspecified
$40M
Other Financing Round
$10M
Other Financing Round
$35M
Unspecified (2008): $500K, investors not publicly disclosed
Private Equity (2010): $1.3M, investors not publicly disclosed
Private Equity (2012): $850K, investors not publicly disclosed
Private Equity (2016): $1.4M, investors not publicly disclosed
Private Equity (2017): $610K, investors not publicly disclosed
Unspecified (2021): $40M with participation from The Arkin Agency and Accelmed
Other Financing Round (2022): $10M, investors not publicly disclosed
Other Financing Round (2022): $35M supported by SWK Holdings and Accelmed
Key Investors in Medminder Systems
SWK Holdings
SWK Holdings is a life science specialty finance company focused on the global healthcare sector, providing innovative capital solutions to life science companies, institutions, and inventors.
Accelmed
Accelmed is a firm investing in HealthTech companies across all stages, with a focus on medical devices, diagnostics, and digital health, operating in both the United States and Israel.
The Arkin Agency
Arkin Capital is a multi-asset manager with specialized arms in health and technology, targeting early to late-stage companies to accelerate growth and deliver impactful solutions.
What's next for Medminder Systems?
With the recent major strategic investment, Medminder Systems is poised for significant advancement. The enterprise-level capital infusion suggests a focus on scaling operations, expanding market reach, and potentially developing new product features or services. This strategic backing will likely enable Medminder to solidify its position in the competitive health tech landscape, further innovating its medication adherence solutions and enhancing its impact on patient well-being. The company's trajectory indicates a strong potential for future growth and market leadership.
See full Medminder Systems company page
